Infectious Complications in Injection Drug Use
- PMID: 33816787
- PMCID: PMC8015638
- DOI: 10.15766/mep_2374-8265.11124
Infectious Complications in Injection Drug Use
Abstract
Introduction: The prevalence of opioid use disorder has increased steadily over the last decade (from 2.2 million in 2010 to 10.2 million in 2018) and with it, a surge in infectious complications associated with injection drug use (IDU). Trainees in internal medicine routinely diagnose, manage, and treat patients experiencing these infections in the hospital setting as well as screen for and immunize against other comorbid infections in the ambulatory setting.
Methods: This 90-minute, case-based, interactive workshop was led by two facilitators, an infectious diseases specialist and a senior internal medicine resident. To evaluate its effectiveness, we used a pre- and postsession survey administered at the beginning and end of the workshop. Learners were asked to rate comfort level in recognizing, managing, and counseling about various IDU-related infections, as well as to answer specific, content-level questions.
Result: Thirty of 42 participants who attended the workshop completed the evaluation. There was a statistically significant change in participants' comfort level with diagnosing and managing IDU-associated infections as well as ambulatory standards of care for people who inject drugs (PWID) from pre- to postworkshop.
Discussion: Our workshop focused on the management and prevention of infections among PWID in both the inpatient and ambulatory settings. Learners demonstrated increased comfort in managing these conditions.
Keywords: Addiction; Case-Based Learning; Endovascular Infection; Infective Endocarditis; Injection Drug Use; Opioid Use Disorder; Opioids; Pain; Pre-Exposure Prophylaxis; Skin and Soft Tissue Infections; Substance Abuse/Addiction.
© 2021 Knodle et al.
References
-
- Centers for Disease Control and Prevention. 2019 Annual Surveillance Report of Drug-Related Risks and Outcomes—United States Surveillance Special Report. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services; 2019. Accessed June 1, 2020. https://www.cdc.gov/drugoverdose/pdf/pubs/2019-cdc-drug-surveillance-rep...
-
- Substance Abuse and Mental Health Services Administration. Results From the 2010 National Survey on Drug Use and Health: Summary of National Findings. Substance Abuse and Mental Health Services Administration; 2011. HHS publication (SMA) 11–4658. Accessed June 1, 2020. https://www.samhsa.gov/data/sites/default/files/NSDUHNationalFindingsRes...
-
- Substance Abuse and Mental Health Services Administration. Results From the 2002 National Survey on Drug Use and Health: National Findings. Substance Abuse and Mental Health Services Administration; 2003. DHHS publication SMA 03–3836. Accessed June 1, 2020. https://files.eric.ed.gov/fulltext/ED479833.pdf
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical